{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:39:15Z","timestamp":1777927155007,"version":"3.51.4"},"reference-count":44,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T00:00:00Z","timestamp":1468800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>HIV medications can be used as post-exposure prophylaxis to efficaciously prevent an HIV-negative person who has come into contact with HIV from becoming HIV-positive. Traditionally, these medications have been available in emergency departments, which have constituted a barrier for the members of many minority groups who are greatly affected by HIV transmission (i.e. gay, bisexual and other men who have sex with men, and persons who use injection drugs). From 5 September 2013 through 4 September 2015, we sought to increase the use of HIV post-exposure prophylaxis by having registered nurses provide these medications, when indicated, in community clinics in Ottawa, Canada. We undertook a chart review of patients who accessed services for HIV post-exposure prophylaxis in this period. Over the two years of data collection, 112 persons requested HIV post-exposure prophylaxis and 64% (n\u2009=\u200972) initiated these medications. Most (93%, or n\u2009=\u200967, of the 72 initiations) were among men, with 88% (n\u2009=\u200959) of these men reporting same sex sexual partners. Among these 58 men, 31% (n\u2009=\u200918) had sexual contact with other men known to be HIV-positive. Among women (n\u2009=\u20098), five initiated post-exposure prophylaxis: three after needle-sharing contact or sexual contact with a male partner who reportedly shared needles, and two after unprotected vaginal sex with a male partner known to be HIV-positive. Overall, no one was diagnosed with HIV at the four-month HIV testing follow-up, although six persons were diagnosed with HIV from the baseline HIV testing, and an additional four were diagnosed with HIV during routine HIV testing one year after completing post-exposure prophylaxis. In total, nine persons in our sample were thus diagnosed with HIV during the study period, which accounted for 9.4% (n\u2009=\u200910 of 106) of all reported HIV diagnoses in Ottawa during this time. We conclude that nurse-initiated HIV post-exposure prophylaxis can be an effective way to provide HIV prevention services to persons who are at high-risk for HIV.<\/jats:p>","DOI":"10.1177\/0956462416658412","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T21:34:02Z","timestamp":1468359242000},"page":"505-511","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":18,"title":["Community-based, nurse-led post-exposure prophylaxis: results and implications"],"prefix":"10.1177","volume":"28","author":[{"given":"Patrick","family":"O\u2019Byrne","sequence":"first","affiliation":[{"name":"School of Nursing, University of Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"MacPherson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ottawa, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Roy","sequence":"additional","affiliation":[{"name":"Ottawa Public Health, Healthy Sexuality and Risk Reduction Unit, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Orser","sequence":"additional","affiliation":[{"name":"Ottawa Public Health, Healthy Sexuality and Risk Reduction Unit, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,7,18]]},"reference":[{"key":"bibr1-0956462416658412","first-page":"iii","volume":"13","author":"Brant J","year":"2009","journal-title":"Health Technol Assess"},{"key":"bibr2-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199711203372101"},{"key":"bibr3-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1038\/nri2302"},{"key":"bibr4-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328321302d"},{"key":"bibr5-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.20.9771-9775.2000"},{"key":"bibr6-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.5.4265-4273.1998"},{"key":"bibr7-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811123392001"},{"key":"bibr8-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108275"},{"key":"bibr9-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008482"},{"key":"bibr10-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1177\/0956462412472826"},{"key":"bibr11-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1111\/phn.12123"},{"key":"bibr12-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2004.tb01428.x"},{"key":"bibr13-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2009.01.024"},{"key":"bibr14-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32833a88a3"},{"key":"bibr15-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283372d90"},{"key":"bibr16-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e3282f2e295"},{"key":"bibr17-0956462416658412","unstructured":"Public Health Agency of Canada. M-Track: enhanced surveillance of HIV, sexually transmitted and blood-borne infections, and associated risk behaviours among men who have sex with men in Canada, http:\/\/librarypdf.catie.ca\/pdf\/ATI-20000s\/26403.pdf (2011, accessed 23 June 2016)."},{"key":"bibr18-0956462416658412","unstructured":"Public Health Agency of Canada. I-Track: enhanced surveillance of risk behaviours among injecting drug users in Canada \u2013 phase 1 report, http:\/\/publications.gc.ca\/collections\/collection_2008\/phac-aspc\/HP40-4-1-2006E.pdf (2006, accessed 23 June 2016)."},{"key":"bibr19-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1177\/0956462414542987"},{"key":"bibr20-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1086\/655651"},{"key":"bibr21-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832b7dca"},{"key":"bibr22-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1086\/512088"},{"key":"bibr23-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1086\/510487"},{"key":"bibr24-0956462416658412","doi-asserted-by":"publisher","DOI":"10.17269\/cjph.105.4471"},{"key":"bibr25-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1016\/j.apnr.2015.06.003"},{"key":"bibr26-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2011.171011"},{"key":"bibr27-0956462416658412","unstructured":"United States Centers for Disease Control and Prevention (CDC). Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV \u2013 United States, 2016, http:\/\/stacks.cdc.gov\/view\/cdc\/38856 (accessed 20 June 2016)."},{"key":"bibr28-0956462416658412","unstructured":"Expert Advisory Group of HIV\/AIDS. Change to recommended regimen for post-exposure prophylaxis (PEP), www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/351633\/Change_to_recommended_regimen_for_PEP_starter_pack_final.pdf (accessed 20 June 2016)."},{"key":"bibr29-0956462416658412","first-page":"354","volume":"59","author":"Mayer KH","year":"2012","journal-title":"J AIDS"},{"key":"bibr30-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2005.017764"},{"key":"bibr31-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1086\/318829"},{"key":"bibr32-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2009.009463"},{"key":"bibr33-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-906"},{"key":"bibr34-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2010.00826.x"},{"key":"bibr35-0956462416658412","unstructured":"Public Health Agency of Canada. Estimates of HIV incidence, prevalence and proportion undiagnosed in Canada, www.catie.ca\/sites\/default\/files\/2014-HIV-Estimates-in-Canada-EN.pdf (2014, accessed 20 June 2016)."},{"key":"bibr36-0956462416658412","unstructured":"Spatz Friedman D, O\u2019Byrne P and Roy M. Comparing those diagnosed early versus late in their HIV infection: implications for public health.\n                      Int J STD\/AIDS\n                      (accepted)."},{"key":"bibr37-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2005.014662"},{"key":"bibr38-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000151"},{"key":"bibr39-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150605"},{"key":"bibr40-0956462416658412","unstructured":"United States Preventive Health Service. PrEP for the Prevention of HIV infection in the US \u2013 2014: a clinical practice guideline, www.cdc.gov\/hiv\/pdf\/prepguidelines2014.pdf (accessed 20 June 2016)."},{"key":"bibr41-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318230e885"},{"key":"bibr42-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2014.0154"},{"key":"bibr43-0956462416658412","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"bibr44-0956462416658412","unstructured":"Kingston-Riechers J. The economic cost of HIV\/AIDS in Canada, www.cdnaids.ca\/files.nsf\/pages\/economiccostofhiv-aidsincanada\/$file\/Economic%20Cost%20of%20HIV-AIDS%20in%20Canada.pdf (2011, accessed 20 June 2016)."}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462416658412","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0956462416658412","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0956462416658412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:36:18Z","timestamp":1777674978000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0956462416658412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,18]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1177\/0956462416658412"],"URL":"https:\/\/doi.org\/10.1177\/0956462416658412","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,18]]}}}